Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells

dc.date.accessioned	2023-03-06T07:33:30Z
dc.date.available	2023-03-06T07:33:30Z
dc.date.issued	2021
dc.identifier.citation	Hum Exp Toxicol. 2021 Jul;40(7):1122-1129. doi: 10.1177/0960327120984209. Epub 2020 Dec 31.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100648
dc.relation.isversionof	10.1177/0960327120984209
dc.relation.isversionof	10.1177/0960327120984209
dc.title	Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells
dc.relation.journal	Hum Exp Toxicol
dc.identifier.doi	10.1177/0960327120984209
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Ozkan AD
dc.contributor.author	Eryilmaz IE
dc.contributor.author	Egeli U
dc.contributor.author	Cecener G.